🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2061)
All (2061)
Buys (180)
Sells (1881)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Kymera Therapeutics, Inc.
(KYMR)
Chadwick Jeremy G
— Chief Operating Officer
Mar 2, 2026
Sale
Shares
1,107
Price
$89.66
Total Value
$99.25K
Shares Held After
77,729
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Chadwick Jeremy G
— Chief Operating Officer
Mar 2, 2026
Sale
Shares
383
Price
$88.50
Total Value
$33.90K
Shares Held After
78,836
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Chadwick Jeremy G
— Chief Operating Officer
Mar 2, 2026
Sale
Shares
549
Price
$87.75
Total Value
$48.18K
Shares Held After
79,219
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Jacobs Bruce N.
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
4,113
Price
$89.66
Total Value
$368.76K
Shares Held After
237,483
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Jacobs Bruce N.
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
1,424
Price
$88.50
Total Value
$126.02K
Shares Held After
241,596
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Jacobs Bruce N.
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
2,039
Price
$87.75
Total Value
$178.92K
Shares Held After
243,020
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Progyny, Inc.
(PGNY)
Swartz Allison
— EVP, GC
Mar 2, 2026
Sale
Shares
2,199
Price
$17.27
Total Value
$37.98K
Shares Held After
97,378
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Annexon, Inc.
(ANNX)
Overdorf Michael
— EVP & CHIEF BUSINESS OFFICER
Mar 2, 2026
Sale
Shares
4,339
Price
$5.42
Total Value
$23.52K
Shares Held After
182,625
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Annexon, Inc.
(ANNX)
Yednock Ted
— EVP & CHIEF INNOVATION OFFICER
Mar 2, 2026
Sale
Shares
5,566
Price
$5.42
Total Value
$30.17K
Shares Held After
154,161
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Annexon, Inc.
(ANNX)
Dananberg Jamie
— CHIEF MEDICAL OFFICER
Mar 2, 2026
Sale
Shares
5,820
Price
$5.43
Total Value
$31.60K
Shares Held After
123,582
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Booth Bruce
— Director
Mar 2, 2026
Sale
Shares
10,052
Price
$90.13
Total Value
$905.99K
Shares Held After
675,341
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Booth Bruce
— Director
Mar 2, 2026
Sale
Shares
71,814
Price
$90.13
Total Value
$6.47M
Shares Held After
3,902,667
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
uniQure N.V.
(QURE)
Potts Jeannette
— Chief Legal Officer
Mar 2, 2026
Sale
Shares
8,578
Price
$9.95
Total Value
$85.35K
Shares Held After
106,495
% of Holdings
7.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Amylyx Pharmaceuticals, Inc.
(AMLX)
Cohen Joshua B
— Director
Mar 2, 2026
Sale
Shares
29,282
Price
$14.48
Total Value
$424.12K
Shares Held After
3,334,683
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Amylyx Pharmaceuticals, Inc.
(AMLX)
FRATES JAMES M
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
7,909
Price
$14.52
Total Value
$114.85K
Shares Held After
165,638
% of Holdings
4.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Annexon, Inc.
(ANNX)
Lew Jennifer
— EVP & CHIEF FINANCIAL OFFICER
Mar 2, 2026
Sale
Shares
5,565
Price
$5.42
Total Value
$30.16K
Shares Held After
170,700
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Annexon, Inc.
(ANNX)
ARTIS DEAN RICHARD
— EVP & CHIEF SCIENTIFIC OFFICER
Mar 2, 2026
Sale
Shares
5,894
Price
$5.43
Total Value
$32.00K
Shares Held After
180,093
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Amylyx Pharmaceuticals, Inc.
(AMLX)
Klee Justin B.
— Director
Mar 2, 2026
Sale
Shares
29,282
Price
$14.47
Total Value
$423.76K
Shares Held After
3,334,616
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Amylyx Pharmaceuticals, Inc.
(AMLX)
Bedrosian Camille L
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
6,461
Price
$14.58
Total Value
$94.21K
Shares Held After
169,295
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Amylyx Pharmaceuticals, Inc.
(AMLX)
Mazzariello Gina
— Chief Legal Officer
Mar 2, 2026
Sale
Shares
6,844
Price
$14.52
Total Value
$99.38K
Shares Held After
134,430
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ceribell, Inc.
(CBLL)
Woo Raymond
— Chief Technology Officer
Mar 2, 2026
Sale
Shares
6,615
Price
$18.25
Total Value
$120.72K
Shares Held After
166,912
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ceribell, Inc.
(CBLL)
Woo Raymond
— Chief Technology Officer
Mar 2, 2026
Sale
Shares
1,472
Price
$18.26
Total Value
$26.88K
Shares Held After
166,912
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MCKESSON CORP
(MCK)
Lau Michele
— EVP and Chief Legal Officer
Mar 2, 2026
Sale
Shares
2,725
Price
$990.00
Total Value
$2.70M
Shares Held After
3,247
% of Holdings
45.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Spyre Therapeutics, Inc.
(SYRE)
Turtle Cameron
— Director
Mar 2, 2026
Sale
Shares
9,100
Price
$42.49
Total Value
$386.66K
Shares Held After
642,540
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Spyre Therapeutics, Inc.
(SYRE)
Turtle Cameron
— Director
Mar 2, 2026
Sale
Shares
5,900
Price
$41.73
Total Value
$246.21K
Shares Held After
651,640
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Chapman Steven Leonard
— Director
Mar 2, 2026
Sale
Shares
365
Price
$201.18
Total Value
$73.43K
Shares Held After
156,607
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Chapman Steven Leonard
— Director
Mar 2, 2026
Sale
Shares
2,463
Price
$200.24
Total Value
$493.19K
Shares Held After
156,972
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Chapman Steven Leonard
— Director
Mar 2, 2026
Sale
Shares
1,122
Price
$199.17
Total Value
$223.47K
Shares Held After
159,435
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
Mar 2, 2026
Sale
Shares
100
Price
$202.85
Total Value
$20.29K
Shares Held After
262,194
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
Mar 2, 2026
Sale
Shares
100
Price
$201.20
Total Value
$20.12K
Shares Held After
262,294
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
Mar 2, 2026
Sale
Shares
2,400
Price
$200.42
Total Value
$481.01K
Shares Held After
262,394
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Sheena Jonathan
— Director
Mar 2, 2026
Sale
Shares
470
Price
$198.50
Total Value
$93.29K
Shares Held After
264,794
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Moshkevich Solomon
— PRESIDENT, CLINICALDIAGNOSTICS
Mar 2, 2026
Sale
Shares
475
Price
$200.97
Total Value
$95.46K
Shares Held After
150,023
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Moshkevich Solomon
— PRESIDENT, CLINICALDIAGNOSTICS
Mar 2, 2026
Sale
Shares
1,594
Price
$200.11
Total Value
$318.97K
Shares Held After
150,498
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Moshkevich Solomon
— PRESIDENT, CLINICALDIAGNOSTICS
Mar 2, 2026
Sale
Shares
931
Price
$198.83
Total Value
$185.11K
Shares Held After
152,092
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABBOTT LABORATORIES
(ABT)
Shroff Eric
— Senior Vice President
Mar 2, 2026
Sale
Shares
709
Price
$115.58
Total Value
$81.95K
Shares Held After
39,164
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABBOTT LABORATORIES
(ABT)
Moreland Mary K
— EXECUTIVE VICE PRESIDENT
Mar 2, 2026
Sale
Shares
613
Price
$115.58
Total Value
$70.85K
Shares Held After
104,291
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENET HEALTHCARE CORP
(THC)
Ramsey R. Scott
— Principal Accounting Officer
Mar 2, 2026
Sale
Shares
1,398
Price
$233.69
Total Value
$326.70K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENET HEALTHCARE CORP
(THC)
Ramsey R. Scott
— Principal Accounting Officer
Mar 2, 2026
Sale
Shares
4,494
Price
$233.21
Total Value
$1.05M
Shares Held After
1,398
% of Holdings
76.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TENET HEALTHCARE CORP
(THC)
Ramsey R. Scott
— Principal Accounting Officer
Mar 2, 2026
Sale
Shares
2,125
Price
$230.98
Total Value
$490.83K
Shares Held After
5,892
% of Holdings
26.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GENELUX Corp
(GNLX)
Thomas John
— Director
Mar 2, 2026
Sale
Shares
10,000
Price
$2.90
Total Value
$28.96K
Shares Held After
482,784
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABBOTT LABORATORIES
(ABT)
Morrone Louis H.
— EXECUTIVE VICE PRESIDENT
Mar 2, 2026
Sale
Shares
1,144
Price
$115.58
Total Value
$132.22K
Shares Held After
76,843
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
Harris Erik
— EVP & Chief Commercial Officer
Mar 2, 2026
Sale
Shares
10,539
Price
$22.80
Total Value
$240.29K
Shares Held After
89,515
% of Holdings
10.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
KAKKIS EMIL D
— Director
Mar 2, 2026
Sale
Shares
54,404
Price
$22.80
Total Value
$1.24M
Shares Held After
658,994
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Murphy Patrick Michael
— CBO and CLO
Mar 2, 2026
Sale
Shares
1,139
Price
$128.45
Total Value
$146.30K
Shares Held After
63,203
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Smith Mervin
— EVP Strategic Business Ops
Mar 2, 2026
Sale
Shares
600
Price
$128.44
Total Value
$77.07K
Shares Held After
25,612
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Murphy Patrick Michael
— CBO and CLO
Mar 2, 2026
Sale
Shares
1,190
Price
$128.44
Total Value
$152.85K
Shares Held After
64,342
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Smith Mervin
— EVP Strategic Business Ops
Mar 2, 2026
Sale
Shares
752
Price
$128.44
Total Value
$96.59K
Shares Held After
26,212
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
iRhythm Holdings, Inc.
(IRTC)
Murphy Patrick Michael
— CBO and CLO
Mar 2, 2026
Sale
Shares
2,028
Price
$128.44
Total Value
$260.47K
Shares Held After
65,532
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Krystal Biotech, Inc.
(KRYS)
ROMANO KATHRYN
— Chief Accounting Officer
Mar 2, 2026
Sale
Shares
750
Price
$267.60
Total Value
$200.70K
Shares Held After
22,366
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1751–1800 of 2061 transactions (page 36 of 42)
Version: v26.3.33